COURT SUSTAINS PATENT ON LILLY SCHIZOPHRENIA DRUG Eli Lilly & Co. v. Zenith Goldline Pharms. | Secondary Sources | Westlaw
https://content.next.westlaw.com/Document/I876e2f0165b611db8a54a698991202fa/View/FullText.html?transitionType=Default&contextData=(sc.Default)
View on Westlaw or start a FREE TRIAL today, COURT SUSTAINS PATENT ON LILLY SCHIZOPHRENIA DRUG Eli Lilly & Co. v. Zenith Goldline Pharms., Secondary Sources
Westlaw Home
Enter to open, tab to navigate, enter to select
Sign in
Sign in
Westlaw Home
All content
Search:
Search Westlaw
Search Tips
Advanced
Skip Page Header
COURT SUSTAINS PATENT ON LILLY SCHIZOPHRENIA DRUG Eli Lilly & Co. v. Zenith Goldline Pharms.
12 No. 1 ANIPLR 5
Andrews Intellectual Property Litigation Reporter
(Approx. 4 pages)
Toggle Menu
COURT SUSTAINS PATENT ON LILLY SCHIZOPHRENIA DRUG Eli Lilly & Co. v. Zenith Goldline Pharms.
12 No. 1 ANIPLR 5
Andrews Intellectual Property Litigation Reporter
(Approx. 4 pages)
12 No. 1 Andrews Intell. Prop. Litig. Rep. 5
Andrews Intellectual Property Litigation Reporter
*1
April 26, 2005
Patent Infringement
Copyright © 2005 Thomson/West .
COURT SUSTAINS PATENT ON LILLY SCHIZOPHRENIA DRUG
Eli Lilly & Co. v. Zenith Goldline Pharms.
A federal judge in Indianapolis has rejected an attempt by three generic drug manufacturers to invalidate Eli Lilly & Co.'s patent on the popular antipsychotic drug, Zyprexa. The ruling bars their attempt to market a generic version of the drug...
End of Document
© 2023 Thomson Reuters. No claim to original U.S. Government Works.
COURT SUSTAINS PATENT ON LILLY SCHIZOPHRENIA DRUG
Eli Lilly & Co. v. Zenith Goldline Pharms.